Aerosol characterization specialist Proveris Scientific has joined the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) as an associate member, the company announced. IPAC-RS now has a total of 16 member pharmaceutical companies and 5 associate members.
Proveris Scientific CEO Dino Farina commented, “We are excited to join IPAC-RS and have our team of experts positively contribute to advancing the global regulatory science of OINDPs via IPAC-RS working groups, technical committees and presentations, and outreach to rapidly developing regions such as India and China.”
Farina added, “We hope to bring to the IPAC-RS community our 20+ years of collective experience working closely with generic and branded pharmaceutical companies, device suppliers, and global regulatory agencies that have provided us a unique perspective on some of the critical challenges that face our industry and how to bridge the knowledge gaps between patient use, formulation, device and regulatory compliance.”
IPAC-RS Chair Robert Berger said, “IPAC-RS welcomes Proveris as an Associate Member. From our earliest days as a consortium, we have appreciated the perspectives and engagement of our supplier members and we look forward to Proveris’ involvement.”
Read the Proveris Scientific press release.
